L. Pradelli, M. Calandriello, R. Di Virgilio, M. Bellone, and M. Tubaro, “Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients”, FE, vol. 15, no. 4, pp. 101–112, Dec. 2014.